IPHA

NASDAQInnate Pharma
High Tide · 73Squeeze · Watch 36NeutralSmart Money · No dataSocial · No data 0
$2.17
$-0.10 (-4.41%)
15-min delayed · Aug 26, 5:25 PMReal-time

Score summary

Buy
Analyst Ratings
3Ratings
2 Buy1 Hold0 Sell
Tide Score
73
High Tide · stable · Top 14% of universe (3876)
Outlook74High Tide · stable · Top 12% of universe (3876)
Squeeze Score
36
Watch ·
  • Days to cover27.54
  • Short interest0.10% of float
  • Borrow rate273.96%
  • Short interest trend-0.01% (30d)
Trend
Recent Smart Money

Key statistics

Market Cap
$252.44M
52-week range
$1.17 – $2.54
94% from low
Day range
$2 – $2
Open $2.22
Volume
27k
vs 283k avg · 10%
P/E (TTM)
Fwd —
Earnings
Sep 17
22d · est $-0.09

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 3 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$7
3 Wall St 12-month targets
High
$9
Average
$6
Low
$2
$1$3$5$7$9HIGH$9MEDIAN$7LOW$2Feb ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 67/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Sep 17 (post-market, est EPS $-0.09) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.